COVID-19 and pediatric fatty liver disease: Is there interplay?

doi:10.3748/wjg.v27.i22.3064

Advanced Search

BPG is committed to discovery and dissemination of knowledge

Home / Archive / Volume 27, Issue 22

This Article

Academic Content and Language Evaluation of This Article

CrossCheck and Google Search of This Article

Academic Rules and Norms of This Article

Citation of this article

Corresponding Author of This Article

Research Domain of This Article

Article-Type of This Article

Open-Access Policy of This Article

Times Cited Counts in Google of This Article

Number of Hits and Downloads for This Article

Total Article Views (5576)

All Articles published online

The chart showing PDF series, WORD series, HTML series, Figures (1-1) series, Tables (1-2) series.

Item

Count

PDF

459

WORD

145

HTML

3335

Figures (1-1)

455

Tables (1-2)

220

Sum=4614

Publishing Process of This Article

The chart showing Browse series, Download series.

Item

Count

Browse

384

Download

578

Sum=962

Jun 14, 2021 (publication date) through Jul 2, 2024

Times Cited of This Article

Times Cited (10)

Journal Information of This Article

Publication Name

World Journal of Gastroenterology

ISSN

1007-9327

Publisher of This Article

Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA

Minireviews

World J Gastroenterol. Jun 14, 2021; 27(22): 3064-3072
Published online Jun 14, 2021. doi: 10.3748/wjg.v27.i22.3064

Open in New Tab Full Size Figure Download Figure

Figure 1 Potential mechanisms linking coronavirus disease 2019 to pediatric fatty liver. ALT: Alanine aminotransferase; AST: Aspartate aminotransferase; COVID-19: Coronavirus disease 2019.

Citation: Di Sessa A, Lanzaro F, Zarrilli S, Picone V, Guarino S, Miraglia del Giudice E, Marzuillo P. COVID-19 and pediatric fatty liver disease: Is there interplay? World J Gastroenterol 2021; 27(22): 3064-3072
URL: https://www.wjgnet.com/1007-9327/full/v27/i22/3064.htm
DOI: https://dx.doi.org/10.3748/wjg.v27.i22.3064